Cargando…
Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
Autores principales: | Lanoy, E, Rosenberg, PS, Fily, F, Lascaux, AS, Martinez, V, Partisani, M, Poizot-Martin, I, Rouveix, E, Engels, EA, Costagliola, D, Goedert, JJ |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002734/ http://dx.doi.org/10.1186/1750-9378-5-S1-A71 |
Ejemplares similares
-
HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence, outcome, and evolution of CD4+ T cell lymphocytes
por: Egger, Matthias
Publicado: (2010) -
Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
por: Kurtin, Sandra E., et al.
Publicado: (2018) -
Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma
por: Engels, E A, et al.
Publicado: (2001) -
Identification of a putative new therapeutical target for Hodgkin's lymphoma
por: Kewitz, Stefanie, et al.
Publicado: (2015) -
Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens
por: Bommenel, T, et al.
Publicado: (2010)